[Contribution of myocardial scintigraphy to control of therapy (current status and outlook)].
Pattern recognition of myocardial ischemia is initially documented in perfusion areas of critical LAD, RCA and LCX stenoses. Prerequisites of the method are mentioned. Possibilities and results of 201Tl myocardial scintigraphy are presented after coronary angioplasty and aortocoronary bypass, further considering lysis therapy of acute infarction, developments to localise infected bypasses or valves, rejection after cardiac transplantation and long-term pharmaceutical exercise-training therapy as well as therapy control of cardiac metabolism.
Hör
G
G
Maul
F D
FD
D000800:Angioplasty, Balloon; D001026:Coronary Artery Bypass; D003326:Coronary Circulation; D003327:Coronary Disease / Q000000981:diagnostic imaging* / Q000601:surgery; D003329:Coronary Vasospasm / Q000000981:diagnostic imaging; D003937:Diagnosis, Differential; D004734:Energy Metabolism; D005080:Exercise Test; D006083:Graft Occlusion, Vascular / Q000000981:diagnostic imaging; D006801:Humans; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000000981:diagnostic imaging; D009206:Myocardium / Q000378:metabolism; D011183:Postoperative Complications / Q000000981:diagnostic imaging; D011379:Prognosis; D011868:Radioisotopes; D011877:Radionuclide Imaging; D013793:Thallium
D011868:Radioisotopes; D013793:Thallium
Beitrag der Myokardszintigraphie in der Therapiekontrolle (Gegenwärtiger Stand und Ausblicke).